Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | -4.00% | +41.18% | +37.14% |
05-29 | Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks | MT |
04-11 | Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+37.14% | 21.33M | |
-3.17% | 8.22B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- Cleo Diagnostics Concludes Design Transfer of Ovarian Cancer Detection Test Technology